Neupro (rotigotine): Reviews and patient testimonials
Back to the list of medications
Medication indications
Neupro 1 mg/24 h and 3mg/24h Transdermal patch for Restless leg syndrome
Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults.
Neupro 2 mg/24 h Transdermal Patch
Restless Legs Syndrome
Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults.
Parkinson's disease
Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or 'on-off' fluctuations).
Neupro 4 mg/24 h, 6 mg/24 h, 8 mg/24 h transdermal patch
Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or 'on-off' fluctuations).
Route of administration: opinion.traitement.transdermal
Molecule: rotigotine
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.